Outlook Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Sukhtian Ghiath M. | — | Award / Grant | 2,460,630 | $1.02 | $2,509,843 | 2,460,630 | Feb 26, 2020 |
| Sukhtian Ghiath M. | — | Option Exercise | 4,657,852 | $0.23 | $1,071,306 | 21,606,437 | Jan 29, 2020 |
| Pillai Arun Kumar | — | Option Exercise | 2,909,091 | $0.23 | $669,091 | 16,948,585 | Dec 23, 2019 |
| KENYON LAWRENCE A | CEO, Pres, CFO, Treas & Secy | Sale | 1,350 | $1.70 | $2,295 | 8,926 | Sep 18, 2019 |
| KENYON LAWRENCE A | CEO, Pres, CFO, Treas & Secy | Sale | 1,350 | $1.70 | $2,295 | 80,863 | Sep 18, 2019 |
| Pillai Arun Kumar | — | Option Exercise | 2,181,818 | — | — | 14,039,494 | Jun 17, 2019 |
| Sukhtian Ghiath M. | — | Award / Grant | 3,636,364 | $2.75 | $10,000,001 | 11,857,676 | Apr 12, 2019 |
| KENYON LAWRENCE A | CEO, Pres, CFO, Treas & Secy | Purchase | 25,000 | $0.90 | $22,500 | 82,213 | Feb 7, 2019 |
| HILZINGER KURT J | — | Purchase | 5,983 | $0.80 | $4,786 | 184,947 | Feb 4, 2019 |
| Sukhtian Faisal Ghiath | — | Award / Grant | 4,288,624 | $0.93 | $3,988,420 | 65,770,503 | Feb 1, 2019 |
| HILZINGER KURT J | — | Purchase | 8,200 | $0.77 | $6,314 | 178,964 | Jan 30, 2019 |
| HILZINGER KURT J | — | Purchase | 5,400 | $0.73 | $3,942 | 159,574 | Jan 28, 2019 |
| HILZINGER KURT J | — | Purchase | 10,749 | $0.68 | $7,309 | 125,196 | Jan 23, 2019 |
| HILZINGER KURT J | — | Purchase | 2,300 | $0.69 | $1,587 | 114,447 | Jan 16, 2019 |
| Mohan Pankaj | — | Purchase | 8,000 | $0.68 | $5,440 | 7,064,553 | Jan 15, 2019 |
| HILZINGER KURT J | — | Purchase | 2,266 | $0.70 | $1,586 | 111,347 | Jan 14, 2019 |
| HILZINGER KURT J | — | Purchase | 2,792 | $0.73 | $2,038 | 98,629 | Jan 10, 2019 |
| HILZINGER KURT J | — | Purchase | 5,166 | $0.63 | $3,255 | 89,427 | Jan 4, 2019 |
| Pillai Arun Kumar | — | Award / Grant | 4,288,624 | $0.93 | $3,988,420 | 61,481,879 | Jan 2, 2019 |
| HILZINGER KURT J | — | Purchase | 11,349 | $0.59 | $6,696 | 72,216 | Jan 2, 2019 |
| HILZINGER KURT J | — | Purchase | 5,714 | $0.54 | $3,086 | 48,227 | Dec 27, 2018 |
| HILZINGER KURT J | — | Purchase | 3,600 | $0.65 | $2,340 | 41,400 | Dec 24, 2018 |
| THURMAN RANDY H | — | Purchase | 15,000 | $0.68 | $10,200 | 15,000 | Dec 21, 2018 |
| BioLexis Pte Ltd. | — | Award / Grant | 4,288,624 | $0.93 | $3,988,420 | 57,193,255 | Dec 3, 2018 |
| BioLexis Pte Ltd. | — | Award / Grant | 8,577,248 | $0.93 | $7,976,841 | 52,904,631 | Nov 7, 2018 |
| KENYON LAWRENCE A | CEO, Pres, CFO, Treas & Secy | Sale | 10,100 | $0.87 | $8,787 | 57,213 | Sep 18, 2018 |
| Bahrt Kenneth | Chief Medical Officer | Sale | 7,700 | $0.85 | $6,545 | 47,120 | Jun 25, 2018 |
| Sukhtian Ghiath M. | — | C | 31,572,617 | — | — | 44,327,383 | May 14, 2018 |
| Mohan Pankaj | President & CEO | Sale | 52,108 | $1.18 | $61,487 | 7,119,122 | Jan 4, 2018 |
| KENYON LAWRENCE A | CFO and Secretary | Sale | 26,165 | $1.13 | $29,566 | 67,313 | Dec 22, 2017 |
| MCANDREW STEPHEN J | SVP Bus. Strat. & Dev. | Sale | 15,705 | $1.13 | $17,747 | 50,899 | Dec 22, 2017 |
| Bahrt Kenneth | Chief Medical Officer | Sale | 26,165 | $1.13 | $29,566 | 54,820 | Dec 22, 2017 |
| Yamashita Elizabeth A. | VP, Regulatory Affairs | Sale | 16,170 | $1.13 | $18,272 | 64,648 | Dec 22, 2017 |
| Yamashita Elizabeth A. | VP, Regulatory Affairs | Sale | 1,509 | $1.17 | $1,766 | 86,969 | Dec 19, 2017 |
| Mohan Pankaj | President & CEO | Sale | 20,523 | $1.17 | $24,012 | 7,254,838 | Dec 19, 2017 |
| HILZINGER KURT J | — | X | 12,036 | $0.01 | $120 | 30,554 | Jan 23, 2017 |
| Bao Kogan | VP, Analytical Sciences | Award / Grant | 50,000 | — | — | 71,739 | Dec 21, 2016 |
| Bahrt Kenneth | Chief Medical Officer | Award / Grant | 50,000 | — | — | 80,985 | Dec 21, 2016 |
| Gangloff Scott A. | SVP, Development & Mfrg | Award / Grant | 40,000 | — | — | 118,573 | Dec 21, 2016 |
| Yamashita Elizabeth A. | VP, Regulatory Affairs | Award / Grant | 45,000 | — | — | 88,478 | Dec 21, 2016 |
| MCANDREW STEPHEN J | SVP Bus. Strat. & Dev. | Award / Grant | 30,000 | — | — | 66,604 | Dec 21, 2016 |
| KENYON LAWRENCE A | CFO and Secretary | Award / Grant | 50,000 | — | — | 93,478 | Dec 21, 2016 |
| Canute Scott A | — | Other | 57,408 | — | — | 246,342 | Nov 28, 2016 |
| HILZINGER KURT J | — | Other | 6,885 | — | — | 18,518 | Nov 28, 2016 |
| Smith Hoke Robin | — | Other | 1,939 | — | — | 1,939 | Nov 28, 2016 |
| Griffith Donald J. | — | Sale | 1 | $3.75 | $4 | 144,926 | Nov 23, 2016 |
| MCANDREW STEPHEN J | SVP Bus. Strat. & Dev. | Option Exercise | 57,971 | — | — | 57,971 | Nov 11, 2016 |
| Gangloff Scott A. | SVP, Development & Mfrg | Sale | 37,369 | $3.75 | $140,134 | 78,573 | Nov 9, 2016 |
| Griffith Donald J. | — | Option Exercise | 144,927 | — | — | 144,927 | Nov 9, 2016 |
| Canute Scott A | — | C | 57,971 | — | — | — | Nov 9, 2016 |